Cambridge Angels group — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Aibuild develops parametric, data-driven software for large format additive manufacturing, helping organizations improve the efficiency of their 3D printing processes.
Advanced ManufacturingAI & Machine LearningRoboticsSaaSLondon, GB
Daghan(Co-founder)inMichail(Co-founder)in
Co-investorsACT Venture PartnersAI SeedAtlas Ventures (UK)First Imagine!SuperSeedActivate Venture Partners+4 more
Breathe develops a battery software toolchain that lets OEMs and battery engineering teams design, simulate, and control lithium batteries to improve cycle life, energy density, and charging while lowering costs.
CleantechDeep TechEnergyHardwareNew MaterialsSaaSLondon, GB
Dr Ian Campbell(Co-founder)Dr Yan Zhao(Chief Technology Officer)Professor Greg Offer(Chief Scientist)Dr Max Naylor Marlow(Head of Testing)Greg Offer(Founder)Ian Campbell(Founder)
Co-investorsKinnevikLowercarbon CapitalSpeedinvestVolvo Cars Tech FundCreative Destruction Lab (CDL)3one4 Capital+3 more
Checkstep provides an AI content moderation platform that combines automated detection, customizable safety workflows, triage, and reporting into a trust and safety system for online platforms and communities.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaSLondon, GB
Guillaume Bouchard(Founder)in
Co-investorsForm VenturesCreative Destruction Lab (CDL)Data TechLook AI VenturesRedbus VenturesChainFund Capital+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Celeris TherapeuticsStamp Free
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












